Interview about the ObsERV platform with Per Norlén

Apr 5, 2023

Presentations

Interview about the ObsERV platform with Per Norlén

In a 7 minutes conversation with Redeye, our CEO Per Norlén explains how leftovers from ancient viruses that infected our ancestors, so-called ERVs, can help us develop an efficient cancer treatment today and in the future.

Redeye Fight Cancer – January 2023

Jan 19, 2023

Presentations

Redeye Fight Cancer – January 2023

Our CEO, Per Norlén, presented at Redeye Fight Cancer on January 19, 2023.

Get to know CEO Per Norlén

Dec 5, 2022

Presentations

Get to know CEO Per Norlén

Redeye interviewed Evaxion’s newly appointed CEO, Per Norlén, about his background, reasons for joining the company, and hopes for the future

BioStock Life Science Fall Summit 2022

Nov 29, 2022

Presentations

BioStock Life Science Fall Summit 2022

Our CEO, Per Norlén, presented the company at BioStock Life Science Fall Summit 2022 in Lund, Sweden. In the video, you can hear more about how we use the power of our AI  to make a unique and personalized treatment for each patient